Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1529211

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1529211

LAMEA Bioimplants Market Size, Share & Trends Analysis Report By End User, By Type, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Bioimplants Market would witness market growth of 10.5% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Others Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $869.4 million by 2031. The Argentina market is showcasing a CAGR of 12.8% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 11% during (2024 - 2031).

Despite the promising advancements and growth in the market, several factors hamper its expansion. High costs associated with developing, producing, and implementing these implants are a significant barrier to widespread adoption. Advanced bioimplants, particularly those involving cutting-edge technologies like tissue engineering and stem cell therapy, require substantial investment in research and development. The manufacturing processes for these implants often involve sophisticated and expensive materials, contributing to their high price.

Ethical concerns related to these implants, especially those derived from human or animal tissues, can also hinder market growth. Issues related to the sourcing and use of stem cells, genetic modification, and animal-derived materials can lead to public and regulatory scrutiny. Ethical debates and public apprehension can hamper the acceptance and adoption of these technologies, affecting market growth. Technological advancements and the rising incidence of accidents and trauma are all contributing to the substantial growth of the market despite these challenges.

Many African countries are currently grappling with a dual burden of chronic non-communicable diseases, including diabetes, cardiovascular diseases, and orthopedic conditions, as well as an increasing prevalence of infectious diseases. To address these challenges, governments and international organizations are working to strengthen healthcare infrastructure and increase access to advanced medical treatments. For example, South Africa, one of Africa's most developed healthcare markets, is seeing increased demand for these implants. The South African government, through its National Health Insurance (NHI) scheme, aims to provide universal health coverage, making advanced treatments more accessible to a broader segment of the population. Hospitals like Groote Schuur Hospital in Cape Town and Chris Hani Baragwanath Hospital in Johannesburg are leading centers for bioimplant surgeries, offering treatments such as hip and knee replacements. Furthermore, international partnerships and collaborations are playing a crucial role in advancing the market in Africa. Organizations such as the World Health Organization (WHO) and the World Bank are working with African governments to fund healthcare projects and provide technical assistance. These collaborations help build the necessary infrastructure and train healthcare professionals to perform advanced procedures involving these implants. Hence, all these factors will aid the market's growth throughout the forecast period.

Based on End User, the market is segmented into Hospitals, Speciality Clinics, and Ambulatory Surgical Centers. Based on Type, the market is segmented into Orthopedic Bioimplants, Cardiovascular Bioimplants, Spinal Bioimplants, Dental Bioimplants, Ophthalmology Bioimplants, and Others.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Stryker Corporation
  • Arthrex, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Medtronic PLC
  • Smith & Nephew PLC
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Victrex plc

LAMEA Bioimplants Market Report Segmentation

By End User

  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centers

By Type

  • Orthopedic Bioimplants
  • Cardiovascular Bioimplants
  • Spinal Bioimplants
  • Dental Bioimplants
  • Ophthalmology Bioimplants
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Bioimplants Market, by End User
    • 1.4.2 LAMEA Bioimplants Market, by Type
    • 1.4.3 LAMEA Bioimplants Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Bioimplants Market by End User

  • 4.1 LAMEA Hospitals Market by Country
  • 4.2 LAMEA Speciality Clinics Market by Country
  • 4.3 LAMEA Ambulatory Surgical Centers Market by Country

Chapter 5. LAMEA Bioimplants Market by Type

  • 5.1 LAMEA Orthopedic Bioimplants Market by Country
  • 5.2 LAMEA Cardiovascular Bioimplants Market by Country
  • 5.3 LAMEA Spinal Bioimplants Market by Country
  • 5.4 LAMEA Dental Bioimplants Market by Country
  • 5.5 LAMEA Ophthalmology Bioimplants Market by Country
  • 5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Bioimplants Market by Country

  • 6.1 Brazil Bioimplants Market
    • 6.1.1 Brazil Bioimplants Market by End User
    • 6.1.2 Brazil Bioimplants Market by Type
  • 6.2 Argentina Bioimplants Market
    • 6.2.1 Argentina Bioimplants Market by End User
    • 6.2.2 Argentina Bioimplants Market by Type
  • 6.3 UAE Bioimplants Market
    • 6.3.1 UAE Bioimplants Market by End User
    • 6.3.2 UAE Bioimplants Market by Type
  • 6.4 Saudi Arabia Bioimplants Market
    • 6.4.1 Saudi Arabia Bioimplants Market by End User
    • 6.4.2 Saudi Arabia Bioimplants Market by Type
  • 6.5 South Africa Bioimplants Market
    • 6.5.1 South Africa Bioimplants Market by End User
    • 6.5.2 South Africa Bioimplants Market by Type
  • 6.6 Nigeria Bioimplants Market
    • 6.6.1 Nigeria Bioimplants Market by End User
    • 6.6.2 Nigeria Bioimplants Market by Type
  • 6.7 Rest of LAMEA Bioimplants Market
    • 6.7.1 Rest of LAMEA Bioimplants Market by End User
    • 6.7.2 Rest of LAMEA Bioimplants Market by Type

Chapter 7. Company Profiles

  • 7.1 Stryker Corporation
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 SWOT Analysis
  • 7.2 Arthrex, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 SWOT Analysis
  • 7.3 Zimmer Biomet Holdings, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
    • 7.3.5 SWOT Analysis
  • 7.4 Medtronic PLC
    • 7.4.1 Company overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expenses
    • 7.4.5 SWOT Analysis
  • 7.5 Smith & Nephew PLC
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional and Segmental Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 SWOT Analysis
  • 7.6 Dentsply Sirona, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 Johnson & Johnson
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental & Regional Analysis
    • 7.7.4 Research & Development Expenses
    • 7.7.5 SWOT Analysis
  • 7.8 Boston Scientific Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 SWOT Analysis
  • 7.9 Abbott Laboratories
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 SWOT Analysis
  • 7.10. Victrex plc
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 LAMEA Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 2 LAMEA Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 3 LAMEA Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 4 LAMEA Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 5 LAMEA Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 6 LAMEA Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 7 LAMEA Speciality Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 8 LAMEA Speciality Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 9 LAMEA Ambulatory Surgical Centers Market by Country, 2020 - 2023, USD Million
  • TABLE 10 LAMEA Ambulatory Surgical Centers Market by Country, 2024 - 2031, USD Million
  • TABLE 11 LAMEA Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 12 LAMEA Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 13 LAMEA Orthopedic Bioimplants Market by Country, 2020 - 2023, USD Million
  • TABLE 14 LAMEA Orthopedic Bioimplants Market by Country, 2024 - 2031, USD Million
  • TABLE 15 LAMEA Cardiovascular Bioimplants Market by Country, 2020 - 2023, USD Million
  • TABLE 16 LAMEA Cardiovascular Bioimplants Market by Country, 2024 - 2031, USD Million
  • TABLE 17 LAMEA Spinal Bioimplants Market by Country, 2020 - 2023, USD Million
  • TABLE 18 LAMEA Spinal Bioimplants Market by Country, 2024 - 2031, USD Million
  • TABLE 19 LAMEA Dental Bioimplants Market by Country, 2020 - 2023, USD Million
  • TABLE 20 LAMEA Dental Bioimplants Market by Country, 2024 - 2031, USD Million
  • TABLE 21 LAMEA Ophthalmology Bioimplants Market by Country, 2020 - 2023, USD Million
  • TABLE 22 LAMEA Ophthalmology Bioimplants Market by Country, 2024 - 2031, USD Million
  • TABLE 23 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 24 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 25 LAMEA Bioimplants Market by Country, 2020 - 2023, USD Million
  • TABLE 26 LAMEA Bioimplants Market by Country, 2024 - 2031, USD Million
  • TABLE 27 Brazil Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 28 Brazil Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 29 Brazil Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 30 Brazil Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 31 Brazil Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 32 Brazil Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 33 Argentina Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 34 Argentina Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 35 Argentina Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 36 Argentina Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 37 Argentina Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 38 Argentina Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 39 UAE Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 40 UAE Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 41 UAE Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 42 UAE Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 43 UAE Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 44 UAE Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 45 Saudi Arabia Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 46 Saudi Arabia Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 47 Saudi Arabia Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 48 Saudi Arabia Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 49 Saudi Arabia Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 50 Saudi Arabia Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 51 South Africa Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 52 South Africa Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 53 South Africa Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 54 South Africa Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 55 South Africa Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 56 South Africa Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 57 Nigeria Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 58 Nigeria Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 59 Nigeria Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 60 Nigeria Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 61 Nigeria Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 62 Nigeria Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 63 Rest of LAMEA Bioimplants Market, 2020 - 2023, USD Million
  • TABLE 64 Rest of LAMEA Bioimplants Market, 2024 - 2031, USD Million
  • TABLE 65 Rest of LAMEA Bioimplants Market by End User, 2020 - 2023, USD Million
  • TABLE 66 Rest of LAMEA Bioimplants Market by End User, 2024 - 2031, USD Million
  • TABLE 67 Rest of LAMEA Bioimplants Market by Type, 2020 - 2023, USD Million
  • TABLE 68 Rest of LAMEA Bioimplants Market by Type, 2024 - 2031, USD Million
  • TABLE 69 Key Information - Stryker Corporation
  • TABLE 70 Key information - Arthrex, Inc.
  • TABLE 71 Key Information - Zimmer Biomet Holdings, Inc.
  • TABLE 72 Key Information - Medtronic PLC
  • TABLE 73 Key Information - Smith & Nephew PLC
  • TABLE 74 key Information - Dentsply Sirona, Inc.
  • TABLE 75 Key Information - Johnson & Johnson
  • TABLE 76 Key Information - Boston Scientific Corporation
  • TABLE 77 Key Information - Abbott Laboratories
  • TABLE 78 Key Information - Victrex plc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!